Frequently asked questions
Questions hospital and laboratory decision makers typically have before starting a partnership.
What is AVC Biotechnology?
AVC Biyoteknoloji is a Turkish company founded in 2022. We are the partner between your institution and a state university hospital laboratory in Turkey: we hold the contract, organise sample logistics, coordinate testing, deliver reports and invoice.
Where are the tests analysed?
At a state university hospital laboratory in Turkey. AVC does not run the analysis itself.
Which tests are available?
39 targeted molecular genetic tests across inherited disorders, reproductive genetics and neurogenetics, immunogenetics and thrombophilia, haematological malignancies and molecular oncology.
Do you offer NGS?
Yes. NGS clinical exome sequencing and gene panels are available on request and reviewed case by case.
Which sample types do you accept, and how are they shipped?
Depending on the test: EDTA whole blood, extracted DNA, dried blood spots, FFPE tissue blocks, bone marrow or prenatal samples. Samples ship as UN3373 Biological Substance, Category B, in triple packaging.
In which languages are reports issued?
English, Arabic or Russian, as agreed with your institution.
How does pricing work?
Contract pricing based on your test menu and monthly volume. Prices and turnaround times are provided on request and agreed in the contract.
Can we start with a pilot?
Yes. A small pilot batch is the usual first step to confirm sample preparation, shipping and reporting.
How do we start?
Send the quote form with your test menu, expected volume and sample types. We reply with a contract proposal.
How is patient data kept confidential?
Samples travel with the minimum data needed for testing, and reports go only to the contacts named in the contract. Data handling terms are set out in the agreement, in line with KVKK and GDPR.